Factors Associated With Improvement Following In‐office Steroid Injections for Vocal Fold Scar
The Laryngoscope · 2024
DOI: 10.1002/lary.31734 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Naomi Tesema und 5 weiteren Autor:innen. Beteiligte Einrichtung: NYU Langone Health, New York, New York, U.S.A. Hauptthemen laut MEDLINE: Vocal Cords, Cicatrix, Voice Quality. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aims to evaluate the clinical outcomes of patients receiving in‐office vocal fold steroid injections (VFSI), highlighting relatively new measures around vocal pitch.
Methods
Patients with a diagnosis of vocal fold scar who received in‐office VFSI from 2013 to 2024 were evaluated. Pre‐ and post‐steroid Voice Handicap Index (VHI‐10) scores, stroboscopic vibratory parameters, acoustic measures of cepstral peak prominence (CPP), and fundamental frequency coefficient of variation (F0CoV) during sustained phonation were analyzed using Wilcoxon signed‐rank tests and McNemar's tests.
Results
Twenty‐two patients had follow‐up data 1–3 months after steroid injection. The median decrease in VHI‐10 after one injection was 4 points ( p = 0.02). We found no difference in CPP and F0CoV measures at follow‐up. Forty‐five percent of patients improved in mucosal wave and amplitude of at least one vocal fold. Earlier presentation from vocal injury was associated with improvement in mucosal wave and amplitude of the left vocal fold ( p = 0.03). We found no difference in sex, tobacco smoking history, singing status, secondary diagnosis, and baseline VHI‐10 score between patients who improved in vibratory parameters and those who did not.
Conclusion
This single‐center study is one of the largest exploring patient outcomes following in‐office VFSI. Though patients reported modest improvement in voice use after VFSI, this may not be as impactful as previously believed. Improvement in videostroboscopy is expected in about half of the patients, with recency from vocal injury a likely predictor of success. These partially negative results provide insight into counseling patients regarding benefits from in‐office VFSI. Level of Evidence 4 Laryngoscope , 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NYU Langone Health, New York, New York, U.S.A.
ORCID-Profile: Naomi Tesema, Mackenzie O'Connor, Aaron M Johnson
Zitieren
APA
Tesema, N., Lackey, T. G., O'Connor, M., Kwak, P. E., Johnson, A. M., & Amin, M. R. (2024). Factors Associated With Improvement Following In‐office Steroid Injections for Vocal Fold Scar. The Laryngoscope. https://doi.org/10.1002/lary.31734
Vancouver
Tesema N, Lackey TG, O'Connor M, Kwak PE, Johnson AM, Amin MR. Factors Associated With Improvement Following In‐office Steroid Injections for Vocal Fold Scar. The Laryngoscope. 2024. doi:10.1002/lary.31734
BibTeX
@article{Tesema2024,
author = {Tesema, Naomi and Lackey, Taylor G and O'Connor, Mackenzie and Kwak, Paul E and Johnson, Aaron M and Amin, Milan R},
title = {Factors Associated With Improvement Following In‐office Steroid Injections for Vocal Fold Scar},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31734}
}
EUVIMED